Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Cardiac pacing and defibrillation studies, and Cardiac Imaging and Diagnostics.
Elevated Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Acute Myocarditis
Neutrophil-to-Lymphocyte Ratio for Risk Stratification in Acute Myocarditis Across the Left Ventricular Ejection Fraction Spectrum
Obesity and cardiovascular disease: an ESC clinical consensus statement
Obesity and cardiovascular disease: an ESC clinical consensus statement
Management of cardiac sarcoidosis
Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry
Heart Failure Specialist Care and Long-Term Outcomes for Patients Admitted With Acute Heart Failure
European Society of Cardiology Quality Indicators Update for the Care and Outcomes of Adults with Heart Failure. The Heart Failure Association of the ESC
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
Prevalence, Clinical Characteristics and Outcomes of Heart Failure Patients with or Without Isolated or Combined Mitral and Tricuspid Regurgitation: An Analysis from the ESC-HFA Heart Failure Long-Term Registry
Acute Heart Failure and Valvular Heart Disease: A Scientific Statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
Artificial Intelligence Methods for Improved Detection of Undiagnosed Heart Failure with Preserved Ejection Fraction
Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry
Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial
Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry
Optimizing Outcomes in Heart Failure: 2022 and Beyond
Hyponatraemia and Changes in Natraemia During Hospitalization for Acute Heart Failure and Associations with In-Hospital and Long-Term Outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial
Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis
European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology
Association of Titin Variations With Late-Onset Dilated Cardiomyopathy
Cardiovascular Outcomes Associated with Treatment of Type 2 Diabetes in Patients with Ischaemic Heart Failure
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the <scp>ESC‐HFA EORP</scp> Heart Failure Long‐Term Registry
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic
Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis
Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy
The collateral cardiovascular damage of COVID-19: only history will reveal the depth of the iceberg